Apo-Tamsulosin CR 0.4 mg (Tamsulosin Hydrochloride TABLET (EXTENDED-RELEASE)) 0.4 MG

APO-Tamsulosin CR 0.4 MG is an extended-release tablet used for managing certain urinary symptoms. This medication, containing tamsulosin hydrochloride, is designed for oral administration and is manufactured by Apotex Inc. in Canada.

Strength

0.4 MG

Pack Size

30/100/500

Manufacturer / TM Owner

APOTEX INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APO-Tamsulosin CR 0.4 MG is commonly used to relieve symptoms associated with an enlarged prostate, such as difficulty urinating. The active ingredient, tamsulosin hydrochloride, works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. This medication is often prescribed for long-term management of these symptoms.

Side Effects

Common effects of APO-Tamsulosin CR 0.4 MG may include dizziness, headache, and fatigue. Some users might experience a drop in blood pressure, leading to lightheadedness. It's important to note that individual responses to the medication can vary.

Precautions & Warnings

APO-Tamsulosin CR 0.4 MG should be taken as directed by a healthcare professional. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. This medication should be stored at room temperature and kept out of reach of children.

Avoid Interactions

APO-Tamsulosin CR 0.4 MG may interact with other medications, including certain blood pressure drugs and other alpha-blockers. It is also advisable to avoid alcohol while taking this medication, as it can enhance the effects of dizziness and lightheadedness.

Frequently Asked Questions

APO-Tamsulosin CR 0.4 MG is used to relieve symptoms of an enlarged prostate, such as difficulty urinating.

APO-Tamsulosin CR 0.4 MG should be taken orally, typically once daily, as directed by your healthcare provider.

Common side effects may include dizziness, headache, and fatigue. Some users might also experience a drop in blood pressure.

It is advisable to avoid alcohol while taking APO-Tamsulosin CR 0.4 MG, as it can enhance the effects of dizziness and lightheadedness.

APO-Tamsulosin CR 0.4 MG should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.